Recent Advances in Optically Controlled PROTAC
Proteolysis-targeting chimera (PROTAC) technology is a groundbreaking therapeutic approach with significant clinical potential for degrading disease-inducing proteins within targeted cells. However, challenges related to insufficient target selectivity raise concerns about PROTAC toxicity toward nor...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI AG
2023-11-01
|
| Collection: | Bioengineering |
| Sujets: | |
| Accès en ligne: | https://www.mdpi.com/2306-5354/10/12/1368 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|